ع
The four-day GCC Rheumatology Conference 2026 drew to a close on February 7 after opening earlier in the week under the patronage of senior Saudi health officials, according to a Saudi Press Agency dispatch. Organizers from the Saudi Society for Rheumatology coordinated the program in partnership with the Saudi Commission for Health Specialties and the Ministry of Health, an arrangement that enabled specialists from all six GCC states to convene and share clinical findings. The gathering, identified in separate announcements as the 12th national rheumatology meeting and the fourth at GCC level, focused on updating protocols for conditions such as rheumatoid arthritis and lupus that affect growing patient cohorts throughout the region.
Session schedules reviewed during the event highlighted both pharmaceutical innovations and multidisciplinary care models, the Saudi Press Agency stated. Participants examined diagnostic imaging improvements and biologic therapies that have altered treatment timelines for inflammatory disorders, topics chosen to address documented rises in prevalence across Gulf populations. Separate coverage of the opening day noted that Advisor to the Custodian of the Two Holy Mosques Dr. Abdullah bin Abdulaziz Al-Rabiah lent official support, signaling alignment between clinical dialogue and national health policy priorities.
A LinkedIn post by consultant rheumatologist Ayah Mohammad Boudal, who chaired the organizing committee, confirmed the conference combined Saudi and GCC tracks to foster cross-border collaboration on research and training. Boudal’s account placed the meeting at King Abdullah Medical Complex venues in Jeddah, where workshops ran alongside plenary lectures for an audience that included practicing physicians, researchers and trainees. The format echoed prior editions that have steadily expanded in scope since the inaugural GCC rheumatology assembly several years earlier.
Regional health statistics underscore the relevance of sustained rheumatology dialogue, according to assessments published by the World Health Organization. Data compiled by the organization place the burden of musculoskeletal disorders among the top contributors to disability-adjusted life years in the Eastern Mediterranean region, a category that includes the six GCC states and has shown upward trends linked to aging demographics and lifestyle shifts. Saudi Ministry of Health figures released in recent years similarly document increased demand for specialized clinics, prompting investment in fellowship programs that several speakers at the conference cited as essential for future workforce capacity.
Closing remarks carried by the Saudi Press Agency emphasized the importance of translating conference outcomes into updated clinical guidelines that can be adopted uniformly across GCC health systems. Attendees committed to follow-up working groups that will track implementation of select recommendations over the coming year, a step that builds on memoranda of understanding signed at previous gatherings. The Saudi Society for Rheumatology indicated that abstracts and presentations would be made available through its digital platform to extend reach beyond those who attended in person.
Parallel coverage of the event’s start on February 4 noted participation by international faculty who contributed perspectives on emerging therapies still under regulatory review in Gulf markets. Those sessions addressed both pediatric rheumatology and transitional care for adolescents, areas where GCC registries have recorded accelerated diagnosis rates. By the conclusion on February 7, organizers had logged multiple side meetings that produced draft proposals for joint research initiatives, according to statements distributed via the official Saudi Press Agency channel.
